Skip to content

Read-only version: For security reasons, the Research Information System (FIS) has been temporarily replaced by this read-only version. All public content and full texts remain available; login, editing, submission and statistics are not available. Questions: fis@uni-bamberg.de

Home › Publications › Corporate social advocacy : medicine, placebo, or poison? : Opportunities and risks for companies and society – and communicative alternatives

Publication

Corporate social advocacy : medicine, placebo, or poison? : Opportunities and risks for companies and society – and communicative alternatives

Hoffjann, Olaf (2025): Corporate social advocacy : medicine, placebo, or poison? : Opportunities and risks for companies and society – and communicative alternatives, in: Public Relations Journal, New York, NY [u.a.]: Public Relations Society of America, Jg. 18, Nr. 2, S. 1–29.

Details

Faculty/Chair
Faculty/Professorship
Author
Title of the Journal
Public Relations Journal
ISSN
1942-4604
Publisher Information
Public Relations Society of America : New York, NY [u.a.]
Year of publication
2025
Volume
18
Issue
2
Language
English
URL
Abstract

In recent years, as societies have become increasingly polarized, companies have been positioning themselves on contemporary and controversial social issues ever more frequently. Over the last few years, there has been a boom in publications on corporate social advocacy (CSA) and in particular in (mostly experimental) stakeholder surveys. This is the starting point for this paper, which goes on to present a theoretical framework and outline practical implications. The paper first discusses the impact of CSA on companies and societal polarization based on existing studies and theoretical considerations (neo-institutionalism). It is clear that CSA appears to be at best a placebo for companies, as large companies with heterogeneous stakeholders in particular are likely to lose more supporters than they gain through such practices. For society, CSA is a poison because it further drives societal polarization. Therefore, companies are not only exacerbating the problems they sought to solve by using CSA, but are also increasingly having to justify their decision not to use CSA. Thus, it appears that it is high time CSA is brought to an end in the interests of both companies and society as a whole. Lastly, concrete alternatives and ways out are outlined. In essence: A medicine to counteract the poison of CSA is presented.

GND Keywords
Öffentlichkeitsarbeit
Keywords
corporate social advocacy
CEO activism
polarization
public relations
strategic communication
DDC Classification
070 News media, journalism & publishing
RVK Classification
AP 17420
Type
Article
URI
Activation date
2026-07-06

Permalink: https://fis.uni-bamberg.de/handle/uniba/115950 · Data as JSON · Cite: BibTeX · RIS

Data as of: 2026-11-15

Restricted read-only access: login, editing and submission are temporarily disabled.